+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 35Years
FEMALE
ID07351747

Study of Laser Acupoint Therapy for Treating Fallopian Tube Obstruction in Women Aged 20 to 35

Led by Kafrelsheikh University · Updated on 2026-01-20

36

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Fallopian tube obstruction is a common health issue affecting many women and can lead to infertility and other reproductive problems. Researchers are studying laser acupoint therapy as a possible treatment to improve the function of the fallopian tubes by using focused laser light directed at specific points linked to reproductive health. This noninvasive and painless therapy may offer benefits over traditional acupuncture by activating the bodys energy pathways to support healing. Participants in this study will be randomly assigned to one of two groups. One group will receive laser acupoint therapy combined with standard care, while the other group will receive a placebo laser acupoint therapy along with standard care. The treatment aims to assess the effect of laser acupoint therapy on fallopian tube obstruction, with no blinding involved. The study starts with treatment and includes follow-up assessments 3 months after treatment. Women who join the study will undergo evaluations including tests to measure tubal patency, anti-Mllerian hormone levels, and pregnancy status three months after treatment. Researchers will monitor these outcomes to understand the therapys impact. Participants must be able to attend all scheduled sessions and follow-up visits. The study is led by Kafrelsheikh University and runs from April 2025 to April 2026.

CONDITIONS

Brief Title

Effect of Laser Acupoints on Fallopian Tube Obstruction

Research Team

H

Hadeer E Shalaby, MBBCH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here